Vaccines — LLMpedia

Vaccines
Photo Credit: James Gathany Content Providers(s): CDC · Public domain · source
Name	Vaccines
Invented	1796
Inventor	Edward Jenner
Type	Biological intervention

Contents

Vaccines are biological preparations that stimulate adaptive immune responses to prevent infectious diseases and reduce morbidity and mortality. They are produced and regulated by institutions such as the World Health Organization, Food and Drug Administration, European Medicines Agency, Centers for Disease Control and Prevention, and manufacturers like GlaxoSmithKline, Pfizer, Moderna, Sanofi, and Johnson & Johnson. Their development, deployment, and evaluation involve collaborations among researchers at universities and institutes including University of Oxford, Harvard University, Johns Hopkins University, Imperial College London, National Institutes of Health, and Pasteur Institute.

History

The modern concept traces to experiments by Edward Jenner in Gloucester and later work by Louis Pasteur in Paris, alongside laboratory scientists such as Robert Koch and clinicians at Guy's Hospital and St Thomas' Hospital. Milestones include the eradication of Smallpox led by campaigns from the World Health Organization and public health efforts in India, Nigeria, and Pakistan, and the near-elimination of Polio through initiatives by Rotary International, Bill & Melinda Gates Foundation, and national programs in United States, Afghanistan, and Egypt. The 20th century saw widespread immunization against pathogens studied by teams at Rockefeller University, Wellcome Trust, Eli Lilly and Company, Bayer, and public programs in United Kingdom, France, Germany, Japan, and Canada, while legal and ethical frameworks evolved through cases adjudicated by courts such as the Supreme Court of the United States and policies set by parliaments in United Kingdom and legislatures in Australia.

Vaccine platforms include live attenuated vaccines developed in laboratories like Walter Reed Army Institute of Research and tested in trials at Beth Israel Deaconess Medical Center; inactivated vaccines produced by companies such as Sinovac and Valneva; subunit and conjugate vaccines pioneered by researchers at Children's Hospital of Philadelphia and Karolinska Institute; toxoid vaccines used historically for Diphtheria and Tetanus and products from Merck & Co.; viral vector vaccines engineered at University of Oxford and licensed by AstraZeneca; and messenger RNA vaccines developed by Moderna and BioNTech with trials at Cleveland Clinic and NYU Langone Health. Immune mechanisms draw on discoveries by Paul Ehrlich, Elie Metchnikoff, Frank Macfarlane Burnet, and Peter Doherty linking humoral and cellular responses measured using assays from laboratories at Salk Institute and Pasteur Institute. Adjuvants such as those patented by GlaxoSmithKline and formulations developed with input from Bill & Melinda Gates Foundation enhance responses via antigen-presenting cells characterized in work at Max Planck Society and Cold Spring Harbor Laboratory.

Preclinical research occurs in facilities including Lawrence Livermore National Laboratory, Brookhaven National Laboratory, and veterinary centers such as Wistar Institute; clinical trials are conducted in phases overseen by regulators like the Food and Drug Administration and coordinated by organizations such as Vaccine Alliance (Gavi) and research networks at University of California, San Francisco, Stanford University, and University of Tokyo. Large efficacy trials were exemplified by studies during the Ebola virus epidemic involving Médecins Sans Frontières and Centers for Disease Control and Prevention, and accelerated pathways used in responses to the COVID-19 pandemic involved collaborations among Operation Warp Speed, European Medicines Agency, and private firms like Pfizer and Moderna. Ethical review boards at institutions including King's College London and Yale University ensure compliance with standards from documents like the Declaration of Helsinki and laws such as the U.S. Food, Drug, and Cosmetic Act.

Safety monitoring is performed by pharmacovigilance systems run by agencies such as the Vaccine Adverse Event Reporting System administered by Centers for Disease Control and Prevention and Food and Drug Administration, and by networks including Sentinel Initiative and the European Pharmacovigilance Risk Assessment Committee. Rare adverse events identified in surveillance have been investigated by academic centers like Mayo Clinic, Massachusetts General Hospital, Karolinska Institute, and London School of Hygiene & Tropical Medicine. Post-licensure studies using databases maintained by National Health Service (England), Medicare, and national registries in Denmark and Sweden have informed risk–benefit assessments communicated by public bodies such as Public Health England and Robert Koch Institute.

Immunization programs run by ministries of health in countries including United States, India, Brazil, South Africa, China, and Nigeria with technical support from World Health Organization and logistics by UNICEF have reduced incidence of Measles, Pertussis, Poliomyelitis, Haemophilus influenzae type b, and Hepatitis B. School-entry requirements enforced in jurisdictions like California and New York (state) and campaigns such as those led by Pan American Health Organization and European Centre for Disease Prevention and Control have shaped uptake. Economic evaluations by institutions such as the World Bank and Organisation for Economic Co-operation and Development estimate cost savings; analyses by Harvard School of Public Health and London School of Economics evaluate return on investment. Cold chain logistics have been improved through innovations from Gavi and private partners including UPS and DHL for distribution to remote areas like Sub-Saharan Africa and Southeast Asia.

Policy debates about mandates and intellectual property involve stakeholders such as World Trade Organization, World Health Organization, Bill & Melinda Gates Foundation, Médecins Sans Frontières, and corporations like Pfizer and Moderna. Access issues are debated in forums including the United Nations General Assembly and handled through mechanisms such as COVAX and bilateral agreements among nations including United States, China, India, Brazil, and South Africa. Ethical issues draw on principles articulated in documents adopted by UNESCO and case law from courts including the European Court of Human Rights and Supreme Court of the United States, with advocacy from organizations like Amnesty International and Human Rights Watch. Vaccine confidence initiatives have been supported by partnerships with NGOs and professional bodies such as the American Medical Association, Royal College of Physicians, and civil society organizations in cities like Geneva, New York City, and London.

Category:Immunology